Outcome MeasurePersonality / Psychological

BSL-23

Borderline Symptom List – 23

1 Paper in Blossom

Outcome Data Across Studies

Reported results for BSL-23 across 1 study with quantitative data.

Outcome data across 2 study arm–timepoint observations
SD
Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder
2023Primary
BPD-positive TRD(experimental)0482.30.8—
Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder
2023Primary
BPD-positive TRD(experimental)10481.6——

Papers Using BSL-23

Paywallindividual

Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder

In a real‑world observational cohort of 66 patients with treatment‑resistant bipolar I/II depression, four sub‑anaesthetic intravenous ketamine infusions over two weeks produced statistically and clinically significant, progressive reductions in depressive symptoms, suicidality and anxiety (mean QIDS‑SR16 reduction 6.08; p<0.0001). Response and remission rates were 35% and 20% respectively, with generally good tolerability (4.5% treatment‑emergent hypomania, no mania or psychosis).

Published
Journal
Bipolar Disorders
Authors
Fancy, F., Rodrigues, N. B., Di Vincenzo, J. D., Chau, E. H., Sethi, A., Husain, M. I., Gill, H., Tabassum, A., Mckenzie, A., Phan, L., McIntyre, R. S., Rosenblat, J. D.

Quick Facts

Full Name
Borderline Symptom List – 23
Domain
Personality / Psychological
Papers Indexed
1
Score Range
0–92
Interpretation
Lower = better
Unit
points
All Measures